Literature DB >> 12627023

Benefit of recombinant human activated protein C beyond 28-day mortality: there is more to life than death.

Marcel Levi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12627023     DOI： 10.1097/01.CCM.0000055386.01914.0C

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  4 in total

1.  An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre.

Authors:  Michael A Fischer; Craig M Lilly; William W Churchill; Lindsey R Baden; Jerry Avorn
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 2.  Sepsis and disseminated intravascular coagulation.

Authors:  Marcel Levi; Evert de Jonge; Tom van der Poll
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

3.  The coagulopathy in sepsis: significance and implications for treatment.

Authors:  Paola Saracco; Pasquale Vitale; Carlo Scolfaro; Berardino Pollio; Mauro Pagliarino; Fabio Timeus
Journal:  Pediatr Rep       Date:  2011-12-12

4.  Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysis.

Authors:  Vania Costa; James M Brophy
Journal:  BMC Anesthesiol       Date:  2007-06-25       Impact factor: 2.217
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.